Expression of cyclooxygenase-2 in human lung carcinoma

Cancer Research

Volumn 58, Issue 22, 1998, Pages 4997-5001

  Wolff, Henrik ^a   Saukkonen, Kirsi ^b   Anttila, Sisko ^a   Karjalainen, Antti ^a   Vainio, Harri ^d   Ristimäki, Ari ^b,c  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASBESTOSIS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY FIBROSIS; RNA, MESSENGER;

EID: 0032533858     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hammar, S. Common neoplasms. In: D. H. Dail and S. P. Hammar (eds.), Pulmonary Pathology, Ed. 2, pp. 1123-1278. New York: Springer-Verlag, 1994.
2. Husgafvel-Pursiainen, K., Ridanpää, M., Anttila, S., and Vainio, H. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures. J. Occup. Environ. Med., 37: 69-76, 1995.
3. Browne, K. Asbestos related disorders. In: W. R. Parkes (ed.), Occupational Lung Disorders, Ed. 3, pp 411-504. London: Butterworth Heinemann, 1994.
4. The respiratory system. In: R. S. Cotran, V. Kumar, and S. L. Robbins (eds.), Pathologic Basis of Disease, Ed. 4, pp. 755-810. Philadelphia: W. B. Sanders Company, 1989.
5. Kodama, T., Biyajima, S., Watanabe, S., and Shimosato, Y. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. Am. J. Clin. Pathol., 85: 146-151, 1986.
6. Miller, R. R., Nelems, B., Evans, K. G., Müller, N. L., and Ostrow, D. D. Glandular neoplasia of the lung. A proposed analogy to colonic tumors. Cancer (Phila.), 61: 1009-1014, 1988.
7. Meyer, E. C., and Liebow, A. A. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer (Phila.), 218: 322-351, 1965.
8. Fox, B., and Ridson, R. A. Carcinoma of the lung and diffuse interstitial pulmonary fibrosis. J. Clin. Pathol., 21: 486-491, 1968.
9. Brody, A. R., McGavran, P. D., and Overby, L. H. Brief inhalation of chrysotile asbestos induces rapid proliferation of bronchiolar-alveolar epithelial and interstitial cells. IARC Sci. Publ., 90: 93-99, 1989.
10. Hughes, J. M., and Weill, H. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br. J. Ind. Med., 48: 229-233, 1991.
11. Karjalainen, A., Anttila, S., Vanhala, E., and Vainio, H. Asbestos exposure and the risk of lung cancer in a general urban population. Scand. J. Work Environ. Health, 20: 243-250, 1994.
12. Wilkinson, P., Hansell, D. M., Janssens, J., Rubens, M., Rudd, R. M., Newman, T. A., and McDonald, C. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet, 345: 1074-1078, 1995.
13. de Klerk, N., Musk, W., Eccles, J., Hansen, J., and Hobbs, M. Exposure to crocidolite and the incidence of different histological types of lung cancer. Occup. Environ. Med., 53: 157-159, 1996.
14. Jagirdar, J., Lee, T. C., Reibman, J., Gold, L. I., Aston, C., Bégin, R., and Rom, W. N. Immunohistochemical localization of transforming growth factor β isoforms in asbestos-related diseases. Environ. Health Perspect., 105(Suppl. 5): 1197-1203, 1997.
15. Greenblatt, M. S., and Harris, C. C. Molecular genetics of lung cancer. Cancer Surv., 25: 293-313, 1995.
16. Thun, M. J. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev., 13: 269-277, 1994.
17. Giardiello, F. M., Offerhaus, G. J. A., and DuBois, R. N. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A: 1071-1076, 1995.
18. IARC. Aspirin. In: IARC Handbooks on Cancer Prevention. I. Non-steroidal Anti-inflammatory Drugs, pp. 43-90. Lyon, France: IARC, 1997.
19. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
20. Harris, R. E., Namboodiri, K. K., and Farrar, W. B. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology, 7: 203-205, 1996.
21. Vane, J. R., and Botting, R. M. Mechanism of action of aspirin-like drugs. Semin. Arthritis Rheum., 26: 2-10, 1997.
22. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
23. Smith, W. L., Garavito, R. M., and DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem., 271: 33157-33160, 1996.
24. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: 6393-6400, 1996.
25. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
26. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
27. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
28. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., and Härkönen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
29. 2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur. J. Cancer, 33: 1508-1512, 1997.
30. Gupta, R. A., and DuBois, R. N. Aspirin, NSAIDs, and colon cancer prevention. Mechanism? Gastroenterology, 114: 1095-1098, 1998.
31. Leong, J., Hughes-Fulford, M., Rakhlin, N., Habib, A., Maclouf, J., and Goldyne, M. E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res., 224: 79-87, 1996.
32. Parrett, M. L., Harris, R., Joarder, F. S., Ross, M. S., Clausen, K. P., and Robertson, F. M. Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol., 10: 503-507, 1997.
33. Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., Wollman, J., Herschman, H., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998.
34. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 118: 5294-5299, 1979.
35. Schmedtje, J. F., Jr., Ji, Y. S., Liu, W. L., DuBois, R. N., and Runge, M. S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272: 601-608, 1997.
36. Parker, J., Kaplon, M. K., Alvarez, C. J., and Krishnaswamy, G. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp. Cell Res., 236: 321-329, 1997.
37. Ermert, L., Goppelt-Struebe, M., Walmrath, D., Grimminger, F., Steudel, W., Ghofrani, H. A., Homberger, C., Duncker, H. R., and Seeger, W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am. J. Respir. Cell Mol. Biol., 18: 479-488, 1998.
38. Scholz, K., Fürstenberger, G., Müller-Deccer, K., and Marks, F. Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem. J., 309: 263-269, 1995.
39. Δ716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell, 87: 803-809, 1996.
40. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
41. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
42. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56: 4424-4429, 1996.
43. Sheng, G. G., Shao, J., Sheng, H., Hooton, E. B., Isakson, P. C., Morrow, J. D., Coffey, R. J., Jr., DuBois, R. N., and Beauchamp, R. D. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology, 113: 1883-1891, 1997.
44. Rodenhuis, S., and Slebos, R. J. C. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52: 2665-2669, 1992.
45. 2 by oncogenic ras in human non-small cell lung cancer. J. Biol. Chem., 272: 4501-4504, 1997.
46. Ohshima, S., Shimizu, Y., and Takahama, M. Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung. Virchows Arch., 424: 129-134, 1994.